[1] |
YU Yong, MA Shouliang, SHENG Yuqin.
Allergic Reactions and Treatment Involving Sodium Dimercaptopropane Sulfate Injection during Copper Chelation for Wilson’s Disease
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 771-775.
|
[2] |
GUO Dongqi, WANG Hao, BAI Xin, BAI Jianqi, SU Hongmei, ZHANG Jingru, GUO Xiaofei, ZHAO Xiaoqi, WANG Min, WANG Yuan, ZHANG Ping.
Identification of Druggable Targets for Intervertebral Disc Degeneration Based on Multi-Omics Data-Driven Mendelian Randomization and Prediction of Traditional Chinese Medicine Interventions
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 241-248.
|
[3] |
NIE Xiaolu, ZHAO Houyu, HUO Donghui, YAN Aixia, SUN Feng, PENG Xiaoxia, NI Xin, ZHAN Siyan.
Pediatric Drug-Induced Immune Thrombocytopenia Based on Real World Data and Quantitative Structure-Activity Relationship
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 16-22.
|
[4] |
DING Xiaoli, HU Xinyue, WANG Xuelei, SUN Yue, LI Jing, ZHANG Hui, Liang Chenggang, WANG Yan.
Quality evaluation of insulin glargine injections
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 644-650.
|
[5] |
LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo.
Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180.
|
[6] |
DU Ying, XIE Yanming, WANG Lianxin, GENG Hongjiao, LI Xiangjie.
Clinical characteristics and drug combination analysis of Lianhua Qingwen capsules (granules) in the real world
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 296-300.
|
[7] |
WANG Yu, HUANG Jingyi, HOU Lixin, LI Shuang, CUI Yongkang, HUANG Lanwei.
Humoral immune characteristics of peripheral blood of CAP patients with antibiotic-associated DILI
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 132-135.
|
[8] |
HOU Tiantian, MA Sisi, WU Xiaobing, HUO Guitao, PAN Dongsheng, WANG Chao, XIA Yan, LIU Yi, ZHOU Xiaobing, LIU Guoqing, GENG Xingchao.
Toxicity of gene therapy drug AAV5-LPLS447X in mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 19-26.
|
[9] |
HOU Tiantian, XIA Yan, PAN Dongsheng, HUO Guitao, MA Xuemei, LIU Ziyang, SUN Li, LIU Yi, YAN Jian'ao, WU Xiaobing, ZHOU Xiaobing, LIU Guoqing, GENG Xingchao.
Toxicity of gene therapy drug AAV5-LPLS447X (GC304) in cynomolgus monkeys
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(1): 27-33.
|
[10] |
DONG Hanshuo, SUN Li, ZHAO Xiaoxiao, WANG Lianxin, YU Xiaokang, XIE Yanming.
Clinical characteristics and drug combination analysis of elemene injectable emulsion in the elderly in the real world
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 845-850.
|
[11] |
YANG Fan, MA Haiping, YOU Mengru, LIAO Sha, LIU Lan, ZHU Jun.
Applications of antiviral drugs in 456 patients with COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 413-416.
|
[12] |
SUN Chunquan, XIE Yanming, HOU Hengyue.
Data mining of clinical characteristics and combined medications of 4 832 patients with heart failure treated with Shengmai injection
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 130-133.
|
[13] |
CHENG Xu, ZHANG Lidan, XIE Yanming, GAO Yang, YANG Yunyun.
Complex network analysis of combined medications of Danshen Ligustrazine injection in the treatment of coronary heart disease complicated with hypertension
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1325-1331.
|
[14] |
LI Lingjun, TAO Lei, WEI Jun, LI Hongyang, CAI Baole, MA Pengcheng.
Effects of a single oral administration of finasteride tablets on bilirubin levels
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1202-1205.
|
[15] |
LI Guowei, LI Likang, LIU Yingxin, WANG Ruoting, WU Darong.
Common problems related to P-value in observational pharmacoepidemiological studies
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(1): 23-26.
|